Closure of patent ductus arteriosus with oversized Amplatzer occluder in a patient with pulmonary hypertension

Karapınar, Hekim; Küçükdurmaz, Zekeriya; Oflaz, Mehmet Burhan; Gül, İbrahim; Yılmaz, Ahmet

doi:10.5114/pwki.2013.34033

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Percutaneous closure of type C PDA is challenged by difficulty in satisfactorily stabilizing the prosthesis due to lack of a sufficient ampulla 5,6 . The ADO-I devices, which have an asymmetric design that allows its skirt to be positioned within the aortic ampulla, leads to the risk of displacement or embolization in the aorta 22,23 in type C PDA, especially with high PA pressure, which is frequently seen in those with CRS. Symmetrically designed devices such as the ADO-II 24 , which has two retention discs that are positioned on both sides of the duct, or occluders for atrial septal defects or muscular ventricular septal defects 25 , are usually used in the hospital for type C PDA to avoid this complication.…”

Section: Discussionmentioning

confidence: 99%

Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome

Toizumi

Motomura

et al. 2019

Sci Rep

View full text Add to dashboard Cite

This study investigated the characteristics of congenital rubella syndrome (CRS)-associated cardiac complications, particularly patent ductus arteriosus (PDA). We reviewed the medical records of patients with CRS who were admitted to the Children’s Hospital 1 in Vietnam between December 2010 and December 2012, and patients with CRS who underwent PDA transcatheter occlusion therapy at the cardiology department between December 2009 and December 2015. We compared the characteristics of PDA treated with transcatheter closure between children with CRS (CRS-PDA) and those without CRS (non-CRS-PDA) who underwent PDA transcatheter closure between July 2014 and December 2015. One-hundred-and-eight children with CRS were enrolled. Cardiac defects (99%), cataracts (72%), and hearing impairment (7%) were detected. Fifty CRS-PDA and 290 non-CRS-PDA patients were examined. CRS-PDA patients had smaller median birthweight (p < 0.001), more frequent pulmonary (p < 0.001) and aortic stenosis (p < 0.001), higher main pulmonary artery pressure, and higher aortic pressure in systole/diastole (p < 0.001 for each) than did non-CRS-PDA patients. The proportion of tubular-type PDA was higher in CRS-PDA patients (16%) than in non-CRS-PDA patients (3%) (p = 0.020). Tubular-type PDA was frequently seen in patients with CRS and accompanied by pulmonary/systemic hypertension and pulmonary/aortic stenosis; in these patients, more cautious device selection is needed for transcatheter PDA closure.

show abstract

Section: Discussionmentioning

confidence: 99%

Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome

Toizumi

Motomura

et al. 2019

Sci Rep

View full text Add to dashboard Cite

show abstract

“…The PDA is muscular only during infancy, when it is more elastic. Therefore, the diameter of the selected occluder should be larger than measured diameter [11]. In our department, we choose occluders that are 4-6 mm larger than the measured diameter.…”

Section: Intraoperative Experiencementioning

confidence: 99%

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Shu

Guo

Wang

et al. 2020

J Cardiothorac Surg

View full text Add to dashboard Cite

Background: Patent ductus arteriosus (PDA) is a common congenital heart disease. Interventional therapy is an important treatment for PDA. Nevertheless, few studies have investigated the safety and effectiveness of interventional therapy for infants (age, 0-36 months) with PDA and moderate-to-severe pulmonary hypertension. Therefore, this study aimed to analyze the short-term (6 months) results and interventional therapy experience for infants with PDA and moderate-to-severe pulmonary hypertension. Methods: Clinical records, echocardiographic data, and angiocardiography data of 28 infants (age, 7-36 months) who underwent interventional therapy for PDA and moderate-to-severe pulmonary hypertension between December 2011 and January 2017 at our hospital were retrospectively analyzed. All infants were treated using an Amplatzer occluder with local and deep sedation anesthesia under radiographic guidance. Results: Infants with PDA and moderate-to-severe pulmonary hypertension had poor growth. Trace residual shunts were found in two infants immediately after procedure; both had disappeared by 6 months after procedure. No significant interventional therapy-related complications occurred in the other cases. Pulmonary systolic pressure, left atrial dimension, and left ventricular end-diastolic dimension immediately after interventional therapy and 6 months later were lower than the preoperative levels (P < 0.05). The left atrial and left ventricular end-diastolic dimensions at 6 months after interventional therapy were smaller than those immediately after interventional therapy (P < 0.05). Pulmonary systolic pressure rates immediately after interventional therapy and 6 months later were not significantly different (P = 0.505). Moreover, there were no significant differences in the left ventricular ejection fraction before, immediately after, and at 6 months after interventional therapy (P = 0.628).

show abstract

Closure of patent ductus arteriosus with oversized Amplatzer occluder in a patient with pulmonary hypertension

Cited by 2 publications

References 10 publications

Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome

Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Contact Info

Product

Resources

About